Estrogen receptor: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 34: | Line 34: | ||
**[[1qkt]] - hERα LBD (mutant) + EST<BR /> | **[[1qkt]] - hERα LBD (mutant) + EST<BR /> | ||
**[[1uom]], [[2ayr]], [[2q70]], [[2qe4]], [[2pog]], [[2r6w]], [[2r6y]], [[2qxs]], [[5u2b]], [[5tn9]], [[5tnb]] - hERα LBD (mutant) + ligand<br /> | **[[1uom]], [[2ayr]], [[2q70]], [[2qe4]], [[2pog]], [[2r6w]], [[2r6y]], [[2qxs]], [[5u2b]], [[5tn9]], [[5tnb]] - hERα LBD (mutant) + ligand<br /> | ||
**[[1err]], [[3ert]], [[1sj0]], [[1yim]], [[1r5k]], [[1xp1]], [[1xp6]], [[1xp9]], [[1xpc]], [[1xqc]], [[1yin]], [[2ouz]], [[2iog]], [[2iok]], [[3dt3]], [[3os8]], [[3os9]], [[3osa ]] - hERα LBD + ligand<br /> | **[[1err]], [[3ert]], [[1sj0]], [[1yim]], [[1r5k]], [[1xp1]], [[1xp6]], [[1xp9]], [[1xpc]], [[1xqc]], [[1yin]], [[2ouz]], [[2iog]], [[2iok]], [[3dt3]], [[3os8]], [[3os9]], [[3osa]], [[5t92]], [[5t97]] - hERα LBD + ligand<br /> | ||
**[[2bj4]], [[2jf9]], [[2jfa]], [[1pcg]] - hERα LBD + peptide antagonist<br /> | **[[2bj4]], [[2jf9]], [[2jfa]], [[1pcg]] - hERα LBD + peptide antagonist<br /> | ||
**[[2yja]] - hERα LBD + stapled peptide<br /> | **[[2yja]] - hERα LBD + stapled peptide<br /> | ||
**[[5hyr]] - hERα LBD (mutant) + stapled peptide + estradiol<br /> | |||
**[[2q6j]], [[2p15]], [[3erd]], [[1l2i]] - hERα LBD + GRIP peptide<br /> | **[[2q6j]], [[2p15]], [[3erd]], [[1l2i]] - hERα LBD + GRIP peptide<br /> | ||
**[[5krh]] - hERα LBD + NCAO2 peptide + benzylidene estrone<br /> | |||
**[[5kri]], [[5krj]], [[5krk]], [[5krl]], [[5krm]], [[5kro]] - hERα LBD (mutant) + NCAO2 peptide + anti-hormone<br /> | |||
**[[5kcf]], [[5kct]], [[5kcu]], [[5kcw, [[5kd9]], [[5kcc]], [[5kcd]] - hERα LBD (mutant) + NCAO2 peptide + OBHS derivative<br /> | |||
**[[5kr9]] - hERα LBD (mutant) + NCAO2 peptide + coumestrol<br /> | |||
**[[5krf]] - hERα LBD (mutant) + peptide + anti-hormone<br /> | |||
**[[2yat]] - hERα LBD (mutant) + EST derivative<br /> | **[[2yat]] - hERα LBD (mutant) + EST derivative<br /> | ||
**[[5fqp]], [[5fqr]], [[5fqs]], [[5fqt]], [[5fqv]] - hERα LBD (mutant) + antagonist<br /> | |||
**[[3uuc]] - hERα LBD + bisphenol<br /> | **[[3uuc]] - hERα LBD + bisphenol<br /> | ||
**[[3q97]] - hERα LBD + LXXLL motif (mutant) + ethoxy triphenylethylene<br /> | **[[3q97]] - hERα LBD + LXXLL motif (mutant) + ethoxy triphenylethylene<br /> | ||
| Line 59: | Line 66: | ||
**[[2g5o]] - hERα LBD + nuclear receptor coactivator 2 peptide + EST derivative<br /> | **[[2g5o]] - hERα LBD + nuclear receptor coactivator 2 peptide + EST derivative<br /> | ||
**[[2qgt]] - hERα LBD (mutant) + nuclear receptor coactivator 2 peptide + EST derivative<br /> | **[[2qgt]] - hERα LBD (mutant) + nuclear receptor coactivator 2 peptide + EST derivative<br /> | ||
**[[5kce]] - hERα LBD (mutant) + nuclear receptor coactivator 2 peptide + OBHS derivative<br /> | |||
**[[1gwq]], [[2fai]], [[2g44]], [[2qzo]] - hERα LBD + nuclear receptor coactivator 2 peptide + ligand<br /> | **[[1gwq]], [[2fai]], [[2g44]], [[2qzo]] - hERα LBD + nuclear receptor coactivator 2 peptide + ligand<br /> | ||
**[[3l03]], [[3hm1]], [[3hlv]], [[1zky]], [[2b1v]], [[2b1z]], [[2qa6]], [[2qab]], [[2qgw]], [[2qh6]], [[2qr9]], [[2qse]], [[2qxm]] - hERα LBD (mutant) + nuclear receptor coactivator 2 peptide + ligand<br /> | **[[3l03]], [[3hm1]], [[3hlv]], [[1zky]], [[2b1v]], [[2b1z]], [[2qa6]], [[2qab]], [[2qgw]], [[2qh6]], [[2qr9]], [[2qse]], [[2qxm]] - hERα LBD (mutant) + nuclear receptor coactivator 2 peptide + ligand<br /> | ||